(Q33932586)

30 July 2017

1 reference

title

Assessing the quality of life in patients with cancer (English)

1 reference

30 July 2017

1 reference

Giesler RB

1

1 reference

30 July 2017

1 March 2000

1 reference

Current Problems in Cancer

30 July 2017

1 reference

30 July 2017

24

1 reference

30 July 2017

58-92

1 reference

30 July 2017

2

1 reference

The quality of life of cancer patients participating in phase I clinical trials using SEIQoL-DW.

30 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2800%2990009-6

7 January 2021

Empirical criteria for the selection of quality-of-life instruments for the evaluation of peripheral blood progenitor cell transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2800%2990009-6

7 January 2021

Quality of life in low-income patients with metastatic prostate cancer: divergent and convergent validity of three instruments.

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2800%2990009-6

7 January 2021

Defining and analysing symptom palliation in cancer clinical trials: a deceptively difficult exercise

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2800%2990009-6

7 January 2021

Linking clinical variables with health-related quality of life. A conceptual model of patient outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2800%2990009-6

7 January 2021

Quality of life assessment in the International Breast Cancer Study Group: past, present, and future.

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2800%2990009-6

7 January 2021

Treating the patient, not just the cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2800%2990009-6

7 January 2021

Methodological and statistical issues of quality of life (QoL) and economic evaluation in cancer clinical trials: report of a workshop.

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2800%2990009-6

7 January 2021

A new approach to the measurement of quality of life. The Patient-Generated Index.

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2800%2990009-6

7 January 2021

Cancer statistics, 1997.

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2800%2990009-6

7 January 2021

Quality of life in long-term survivors of adult-onset cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2800%2990009-6

7 January 2021

Treatment of testicular cancer: a new and improved model

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2800%2990009-6

7 January 2021

Measuring the quality of life of cancer patients: the Functional Living Index-Cancer: development and validation

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2800%2990009-6

7 January 2021

Quality of life in cancer: definition, purpose, and method of measurement

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2800%2990009-6

7 January 2021

Theoretical issues pertinent to measurement of quality of life

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2800%2990009-6

7 January 2021

Measuring health-related quality of life

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2800%2990009-6

7 January 2021

Life after breast cancer: understanding women's health-related quality of life and sexual functioning

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2800%2990009-6

7 January 2021

Functional status and quality of life: predictors of early mortality among patients entering treatment for end stage renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2800%2990009-6

7 January 2021

A randomised trial of three or six courses of etoposide cyclophosphamide methotrexate and vincristine or six courses of etoposide and ifosfamide in small cell lung cancer (SCLC). II: Quality of life. Medical Research Council Lung Cancer Working Part

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2800%2990009-6

7 January 2021

Quality of life assessment in a cross-cultural context: use of the Rotterdam Symptom Checklist in a multinational randomised trial comparing CMF and Zoladex (Goserlin) treatment in early breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2800%2990009-6

7 January 2021

Quality of life assessment in daily clinical oncology practice: a feasibility study.

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2800%2990009-6

7 January 2021

Prostate cancer practice patterns and quality of life: the Prostate Cancer Outcomes Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2800%2990009-6

7 January 2021

RTOG's first quality of life study--RTOG 90-20: a phase II trial of external beam radiation with etanidazole for locally advanced prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2800%2990009-6

7 January 2021

Assessing quality of life after surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2800%2990009-6

7 January 2021

Subjective well-being.

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2800%2990009-6

7 January 2021

Assessment of quality-of-life outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2800%2990009-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS0147-0272%2800%2990009-6

1 reference

7 January 2021

Improving the quality of life during chemotherapy for advanced breast cancer. A comparison of intermittent and continuous treatment strategies.

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2800%2990009-6

7 January 2021

The impact of breast-conserving treatment and mastectomy on the quality of life of early-stage breast cancer patients: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2800%2990009-6

7 January 2021

The Functional Assessment of Cancer Therapy scale: development and validation of the general measure

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2800%2990009-6

7 January 2021

The European Organization for Research and Treatment of Cancer approach to developing questionnaire modules: an update and overview. EORTC Quality of Life Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2800%2990009-6

7 January 2021

The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2800%2990009-6

7 January 2021

Assessment of quality of life with a single instrument

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2800%2990009-6

7 January 2021

Methods for quality-of-life studies

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2800%2990009-6

7 January 2021

The UCLA Prostate Cancer Index: development, reliability, and validity of a health-related quality of life measure

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2800%2990009-6

7 January 2021

Quality of life following intensive care.

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2800%2990009-6

7 January 2021

Quality of life and social production functions: a framework for understanding health effects.

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2800%2990009-6

7 January 2021

The role of health care providers and significant others in evaluating the quality of life of patients with chronic disease: A review

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2800%2990009-6

7 January 2021

Outcomes of recognized and unrecognized depression in an international primary care study.

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2800%2990009-6

7 January 2021

Scientific problems in clinical scales, as demonstrated in the Karnofsky index of performance status

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2800%2990009-6

7 January 2021

Measuring the quality of life of cancer patients: a concise QL-index for use by physicians.

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2800%2990009-6

7 January 2021

The MOS 36-ltem Short-Form Health Survey (SF-36)

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2800%2990009-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2800%2990009-6

7 January 2021

Computerized psychometry screening in long-term survivors of childhood acute lymphoblastic leukemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2800%2990009-6

7 January 2021

Convergent discriminitive, and predictive validity of the Prostate Cancer Specific Quality of Life Instrument (PROSQOLI) assessment and comparison with analogous scales from the EORTC QLQ-C30 and a trial-specific module. European Organisation for Re

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2800%2990009-6

7 January 2021

The Sickness Impact Profile: Development and Final Revision of a Health Status Measure

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2800%2990009-6

7 January 2021

Quality of life: conceptual issues.

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2800%2990009-6

7 January 2021

CAncer Rehabilitation Evaluation System--short form (CARES-SF). A cancer specific rehabilitation and quality of life instrument

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2800%2990009-6

7 January 2021

Women's sexual self-schema

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2800%2990009-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2800%2990009-6

7 January 2021

Reproducibility and responsiveness of health status measures. Statistics and strategies for evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2800%2990009-6

7 January 2021

Interpreting the significance of changes in health-related quality-of-life scores.

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2800%2990009-6

7 January 2021

Methodology for measuring health-state preferences--I: Measurement strategies

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2800%2990009-6

7 January 2021

Incorporating utility-based quality-of-life assessment measures in clinical trials. Two examples

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2800%2990009-6

7 January 2021

Measurement of health state utilities for economic appraisal

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2800%2990009-6

7 January 2021

Variation in patient utilities for outcomes of the management of chronic stable angina. Implications for clinical practice guidelines. Ischemic Heart Disease Patient Outcomes Research Team

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2800%2990009-6

7 January 2021

Health values of the seriously ill. SUPPORT investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2800%2990009-6

7 January 2021

Methods for assessing relative importance in preference based outcome measures

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2800%2990009-6

7 January 2021

Assessing the performance of utility techniques in the absence of a gold standard.

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2800%2990009-6

7 January 2021

Measurement of the validity of utility elicitations performed by computerized interview

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2800%2990009-6

7 January 2021

Quality-of-life-adjusted evaluation of adjuvant therapies for operable breast cancer. The International Breast Cancer Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2800%2990009-6

7 January 2021

Quality of life assessment in the adjuvant setting: is it relevant? International Breast Cancer Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2800%2990009-6

7 January 2021

Quality-adjusted survival (Q-TWiST) analysis of EORTC trial 30853: comparing goserelin acetate and flutamide with bilateral orchiectomy in patients with metastatic prostate cancer. European Organization for Research and Treatment of Cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2800%2990009-6

7 January 2021

The danger of applying group-level utilities in decision analyses of the treatment of localized prostate cancer in individual patients

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2800%2990009-6

7 January 2021

Variability among methods to assess patients' well-being and consequent effect on a cost-effectiveness analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2800%2990009-6

7 January 2021

Preferences for health outcomes. Comparison of assessment methods

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2800%2990009-6

7 January 2021

Opportunities and challenges: assessing quality of life in clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2800%2990009-6

7 January 2021

Measurement of health status. Ascertaining the minimal clinically important difference

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2800%2990009-6

7 January 2021

Assessing the consistency of psychometric properties of the HRQoL scales within the EORTC QLQ-C30 across populations by means of the Mokken Scaling Model.

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2800%2990009-6

7 January 2021

Psychosocial outcomes of breast-conserving surgery versus mastectomy: a meta-analytic review

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2800%2990009-6

7 January 2021

Integrating bottom-up and top-down theories of subjective well-being: the case of health.

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2800%2990009-6

7 January 2021

The independence of positive and negative affect.

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2800%2990009-6

7 January 2021

10.1016/S0147-0272(00)90009-6

Identifiers

DOI

1 reference

30 July 2017

1 reference

PubMed ID

10836799